Dr Kristin-Anne Rutter leads the development and delivery of a collaborative life sciences strategy for the Cambridge cluster. The goal of the strategy is to accelerate the creation of breakthrough scientific discoveries, demonstrate that they work in real world populations and then deliver them rapidly and at scale to benefit NHS patients and grow the UK economy.
To boost industry-NHS collaboration and innovation, Kristin-Anne is delivering three major programmes. She currently leads the Secure Data Environment for the East of England, which helps researchers and AI developers access large patient datasets in a bid to find new treatments for common, yet currently incurable conditions. She ran a workstream of the recent NHSE Innovation Ecosystem Review, which lays out in depth how the NHS can become a better innovation partner to industry. And she is establishing new Innovation Landing Zones in Cambridge NHS trusts, to support the testing and adoption of innovation including AI.
Kristin-Anne joined CUHP from McKinsey & Company, where she was a partner focussing on improvement and innovation in healthcare delivery and the founder of the McKinsey Health Tech network, bringing together the most innovative tech and digital solution providers and supporting them to deploy in health systems. She supported the UK government to identify opportunities to strengthen the UK Life science industry and the deployment of innovation in the NHS.
Prior to joining McKinsey, Kristin-Anne worked as a doctor in Iceland and she currently Chairs the Audit and Risk committee of MSI International.
